Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10794688 | 0.78 | TSHR (0.46) | TSHRTDP1 | |
| SCHEMBL5995512 | 0.78 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL13458323 | 0.76 | TSHR (0.38) | TSHRTDP1 | |
| SCHEMBL1973735 | 0.75 | — | — | |
| SCHEMBL10975 | 0.73 | — | — | |
| SCHEMBL1398293 | 0.73 | — | — | |
| SCHEMBL83728 | 0.73 | — | — | |
| SCHEMBL17607595 | 0.73 | TSHR (0.35) | TSHRTDP1 | |
| SCHEMBL6441329 | 0.73 | — | — | |
| SCHEMBL17607672 | 0.73 | TSHR (0.35) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112673009-B | Substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-112771046-B | Other substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-11518756-B2 | Arylation method | UMICORE AG & CO. KG (DE) | 2022-12-06 | — | — | US | disclosed |
| EP-3383861-B1 | BUCHWALD-HARTWIG ARYLATION METHOD FOR THE PREPARATION OF TERTIARY AMINES | UMICORE AG & CO KG (DE) | 2021-03-17 | — | — | EP | disclosed |
| US-10570097-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-02-25 | — | — | US | disclosed |
| US-20200031803-A1 | ARYLATION METHOD | UMICORE AG & CO. KG (DE) | 2020-01-30 | — | — | US | disclosed |
| CN-105969543-B | Flue dust cleaning agent after fire | 江苏筑磊电子科技有限公司 | 2019-04-05 | — | — | CN | disclosed |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-01-17 | — | — | US | disclosed |
| US-10160728-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-12-25 | — | — | US | disclosed |
| EP-3060548-B1 | MONO ARYLATION OF AROMATIC AMINES | UMICORE AG & CO KG (DE) | 2018-10-10 | — | — | EP | disclosed |
| US-9469662-B2 | Process for preparing optically active biophosphinylalkanes | BASF SE (DE) | 2016-10-18 | — | — | US | disclosed |
| CN-105969543-A | Smoke dust cleaning agent after fire hazards | 江苏筑磊电子科技有限公司 | 2016-09-28 | — | — | CN | disclosed |
| EP-3060548-A1 | MONOARYLATION OF AROMATIC AMINES | Umicore AG & Co. KG (DE) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015059049-A1 | MONOARYLATION OF AROMATIC AMINES | UMICORE AG & CO. KG (DE) | 2015-04-30 | — | — | WO | disclosed |
| CN-101253183-B | Process for preparing optically active diphosphanes | BASF SE | 2013-07-10 | — | — | CN | disclosed |
| EP-1913007-B1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2011-06-22 | — | — | EP | disclosed |
| US-20080242893-A1 | Process for Preparing Optically Active Diphosphanes | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
| CN-101253183-A | Process for preparing optically active diphosphanes | BASF SE (DE) | 2008-08-27 | — | — | CN | disclosed |
| EP-1913007-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007012655-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2007-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570097-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | TSHR 3989/4885TDP1 4399/4885 |
| US-10160728-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | TSHR 3989/4885TDP1 4399/4885 |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | TSHR 3989/4885TDP1 4399/4885 |
| US-11518756-B2 | Arylation method | AHR, ARNT, CYP2B6 | TSHR 555/4885TDP1 3735/4885 |
| US-20200031803-A1 | ARYLATION METHOD | AHR, ARNT, CYP2B6 | TSHR 555/4885TDP1 3735/4885 |
| US-20080242893-A1 | Process for Preparing Optically Active Diphosphanes | PHOSPHO1, DCTPP1, DCPS | TSHR 4357/4885TDP1 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.